1. Azari, J., Brumbaugh, P., and Huxtable, R.J., 1980, Prophylaxis by taurine in the hearts of cardiomyopathic hamsters, J. Mol. Cell. Cardiol., 12:1353–1366.
2. Azuma, J., Sawamura, A., Awata, N., Hasegawa, H., Ogura, K., Harada, H., Ohata, H., Yamauchi, K., Kishimoto, S., Yamagami, T., Ueda, E., and Ishiyama, T., 1983, Double blind randomized crossover trial of taurine in congestive heart failure, Curr. Therap. Res., 34:543–557.
3. Azuma, J., Takihara, K., Awata, N., Ohata, H., Sawamura, A., Harada, H., and Kishimoto, S., 1984, Benefician effect of taurine on congestive heart failure induced by chronic aortic regurgitation in rabbits, Res. Commun. Chem. Pathol. Pharmacol., 45:261–270.
4. Bunger, R., Swindall, B., Brodie, D., Zdunek, D., Stiegler, H., and Walter, G., 1986, Pyruvate attenuation of hypoxia damage in isolated working guinea pig heart, J. Mol. Cell. Cardiol., 18:423–438.
5. Chovan, J.P., Kulakowski, E.C., Sheakowski, S., and Schaffer, S.W., 1980, Calcium regulation by the low-affinity taurine binding sites of cardiac sarcolemma, Mol. Pharmacol., 17:295–300.